Literature DB >> 6248438

Endocrine profile and therapeutic employment of a new prolactin-lowering drug, metergoline.

C Ferrari, E Reschini, M Peracchi, P G Crosignani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248438     DOI: 10.1159/000299801

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


× No keyword cloud information.
  4 in total

1.  Evaluation of [(11)C]metergoline as a PET radiotracer for 5HTR in nonhuman primates.

Authors:  Jacob M Hooker; Sung Won Kim; Achim T Reibel; David Alexoff; Youwen Xu; Colleen Shea
Journal:  Bioorg Med Chem       Date:  2010-04-20       Impact factor: 3.641

2.  Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans.

Authors:  E A Mueller; D L Murphy; T Sunderland
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.

Authors:  F Scapin; S Buonaccorsi; G Tronconi; G Pellicciotta; A E Pontiroli
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Selective and extremely long inhibition of prolactin release in man by 1-ethyl-3-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta- carbonyl)-urea-diphosphate (FCE 21336).

Authors:  A E Pontiroli; G C Viberti; R Mangili; L Cammelli; A Dubini
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.